FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America Obagi-C Rx System C-Therapy Night Cream Recall

Obagi-C Rx System C-Therapy Night Cream

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Jul 26, 2017
Recall ID
D-0998-2017
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Obagi-C Rx System C-Therapy Night Cream starting Jun 28, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0998-2017 on Jul 26, 2017. Reason: Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Product description

Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02

Lot numbers, UPCs & expiration codes

Lot #: 2578400, 0Exp 8/2019

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0998-2017
Classification
Class III
Status
Terminated
Recall initiated
Jun 28, 2017
FDA report date
Jul 26, 2017
Quantity
844 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0998-2017, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
77659
Address
400 Somerset Corporate Blvd
Code information
Lot #: 2578400, 0Exp 8/2019
Postal code
08807-2867
Report date
Jul 26, 2017
Product type
Drugs
Recall number
D-0998-2017
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
844 bottles
Termination date
Jan 16, 2018
Reason for recall
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02
Distribution pattern
U.S. Nationwide
Recall initiation date
Jun 28, 2017
Initial firm notification
Letter
Center classification date
Jul 14, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0998-2017, published Jul 26, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls